Page last updated: 2024-09-04

resiquimod and catechin

resiquimod has been researched along with catechin in 2 studies

Compound Research Comparison

Studies
(resiquimod)
Trials
(resiquimod)
Recent Studies (post-2010)
(resiquimod)
Studies
(catechin)
Trials
(catechin)
Recent Studies (post-2010) (catechin)
4651431811,5444776,612

Protein Interaction Comparison

ProteinTaxonomyresiquimod (IC50)catechin (IC50)
Arginase Leishmania amazonensis1.7

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Cao, G; Geng, J; Li, D; Li, H; Li, Y; Song, Q; Wang, B; Wang, Y; Zhang, G; Zhang, Y1

Other Studies

2 other study(ies) available for resiquimod and catechin

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Reinforcing the Combinational Immuno-Oncotherapy of Switching "Cold" Tumor to "Hot" by Responsive Penetrating Nanogels.
    ACS applied materials & interfaces, 2021, Aug-11, Volume: 13, Issue:31

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents; B7-H1 Antigen; Catechin; Cell Line, Tumor; Dendritic Cells; Drug Carriers; Drug Liberation; Female; Hyaluronic Acid; Imidazoles; Immunomodulation; Mice, Inbred C57BL; Nanogels; Neoplasms; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Tumor Microenvironment

2021